Gamma-hydroxybutyrate--a drug of abuse (Q36566720)

15 August 2017

1 reference

title

Gamma-hydroxybutyrate--a drug of abuse (English)

1 reference

15 August 2017

Drasbek KR

1

1 reference

15 August 2017

Christensen J

series ordinal

2

1 reference

15 August 2017

Jensen K

series ordinal

3

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 September 2006

1 reference

Acta Neurologica Scandinavica

15 August 2017

published in

1 reference

15 August 2017

volume

114

1 reference

15 August 2017

issue

3

1 reference

15 August 2017

page(s)

145-156

1 reference

Binding sites for [3H]gamma-hydroxybutyrate on cultured neurones of rat cerebellum and spinal cord

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

Gamma-hydroxybutyrate withdrawal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

The gamma-hydroxybutyrate withdrawal syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

Suspicious death related to gamma-hydroxybutyrate (GHB) toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 30-2003. A 21-year-old man with sudden alteration of mental status

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

Agitation is common in gamma-hydroxybutyrate toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

GHB: a new and novel drug of abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

Gamma hydroxybutirate use for sexual assault

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

The gamma-hydroxybutyrate signalling system in brain: organization and functional implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

Evidence for a gamma-hydroxybutyrate (GHB) uptake by rat brain synaptic vesicles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

Evidence for a G protein-coupled gamma-hydroxybutyric acid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

Direct modulation of synaptic vesicle priming by GABA(B) receptor activation at a glutamatergic synapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

gamma-Aminobutyric acidB receptors in the rat brain: quantitative autoradiographic localization using [3H](-)-baclofen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

Gamma-hydroxybutyrate reduces mitogen-activated protein kinase phosphorylation via GABA B receptor activation in mouse frontal cortex and hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

Bi-directional effects of GABA(B) receptor agonists on the mesolimbic dopamine system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

GHB depresses fast excitatory and inhibitory synaptic transmission via GABA(B) receptors in mouse neocortical neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

Effects of GABA agonists on body temperature regulation in GABA(B(1))-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

Role of GABA(B) receptors in the sedative/hypnotic effect of gamma-hydroxybutyric acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

Discriminative stimulus effects of gamma-hydroxybutyrate (GHB) in rats discriminating GHB from baclofen and diazepam

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

The ontogeny of [3H]gamma-hydroxybutyrate and [3H]GABAB binding sites: relation to the development of experimental absence seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

Specific gamma-hydroxybutyrate-binding sites but loss of pharmacological effects of gamma-hydroxybutyrate in GABA(B)(1)-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

Gamma-hydroxybutyric acid (GHB) and gamma-aminobutyric acidB receptor (GABABR) binding sites are distinctive from one another: molecular evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

Therapeutic intervention in mice deficient for succinate semialdehyde dehydrogenase (gamma-hydroxybutyric aciduria)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

Novel cyclic gamma-hydroxybutyrate (GHB) analogs with high affinity and stereoselectivity of binding to GHB sites in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

The effects of gamma-hydroxybutyrate on the membrane properties of guinea-pig pars compacta neurons in the substantia nigra in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

Inhibition of firing rate and changes in the firing pattern of nigral dopamine neurons by gamma-hydroxybutyric acid (GHBA) are specifically induced by activation of GABA(B) receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

Gamma-hydroxybutyrate and cocaine administration increases mRNA expression of dopamine D1 and D2 receptors in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

Gamma-hydroxybutyrate and ethanol depress spontaneous excitatory postsynaptic currents in dopaminergic neurons of the substantia nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

Presynaptic modulation of spontaneous inhibitory postsynaptic currents by gamma-hydroxybutyrate in the substantia nigra pars compacta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

Immunohistochemical studies of the localization of neurons containing the enzyme that synthesizes dopamine, GABA, or gamma-hydroxybutyrate in the rat substantia nigra and striatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

Gamma-hydroxybutyrate increases tryptophan availability and potentiates serotonin turnover in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

Significant behavioral disturbances in succinic semialdehyde dehydrogenase (SSADH) deficiency (Gamma-Hydroxybutyric aciduria)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

GABA(B) receptor-mediated increase of neurosteroids by gamma-hydroxybutyric acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

Neuroactive steroids reduce neuronal excitability by selectively enhancing tonic inhibition mediated by delta subunit-containing GABAA receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

Failure of gamma-hydroxybutyric acid both to increase neuroactive steroid concentrations in adrenalectomized-orchiectomized rats and to induce tolerance to its steroidogenic effect in intact animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

Brain steroidogenesis mediates ethanol modulation of GABAA receptor activity in rat hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

Effect of anesthetic doses of gamma-hydroxybutyrate on the acetylcholine content of rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

gamma-Hydroxybutyric acid and baclofen decrease extracellular acetylcholine levels in the hippocampus via GABA(B) receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

Different control of GH secretion by gamma-amino- and gamma-hydroxy-butyric acid in 4-year abstinent alcoholics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

Long-term administration of GHB does not affect muscular mass in alcoholics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

Muscarinic cholinergic mediation of the GH response to gamma-hydroxybutyric acid: neuroendocrine evidence in normal and parkinsonian subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

The anxiolytic effect of γ-hydroxybutyrate in the elevated plus maze is reversed by the benzodiazepine receptor antagonist, flumazenil

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

Dose-dependent absorption and elimination of gamma-hydroxybutyric acid in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

gamma-Hydroxybutyrate: a health-food product producing coma and seizurelike activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

Metabolism of gamma-hydroxybutyrate to d-2-hydroxyglutarate in mammals: further evidence for d-2-hydroxyglutarate transhydrogenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

Pharmacokinetics of gamma-hydroxybutyric acid in alcohol dependent patients after single and repeated oral doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

Effect of moderate or severe liver dysfunction on the pharmacokinetics of gamma-hydroxybutyric acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

The relationship between club drug use and other drug use: a survey of New York City middle school students

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

Suspected GHB overdoses in the emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

Clinical features of gamma-hydroxybutyrate and gamma-butyrolactone toxicity and concomitant drug and alcohol use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

Physostigmine does not effect arousal but produces toxicity in an animal model of severe gamma-hydroxybutyrate intoxication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

The effects and consequences of selected club drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

Severe gamma-hydroxybutyrate withdrawal: a case report and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

Gamma-hydroxybutyric acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

Medications for the treatment of narcolepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

Further evidence supporting the use of sodium oxybate for the treatment of cataplexy: a double-blind, placebo-controlled study in 228 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

Gamma-hydroxybutyric acid (GHB) in the treatment of alcohol withdrawal syndrome: a randomized comparative study versus benzodiazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

An open multicentric study evaluating 4-hydroxybutyric acid sodium salt in the medium-term treatment of 179 alcohol dependent subjects. GHB Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

The role of gamma-hydroxybutyric acid in the treatment of alcoholism: from animal to clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

An EEG-behavioral study of sodium hydroxybutyrate in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

EEG and behavioral effects of gamma-hydroxybutyrate in the rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

Resuscitative effect of a gamma-aminobutyric acid B receptor antagonist on gamma-hydroxybutyric acid mortality in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

SGS742: the first GABA(B) receptor antagonist in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

Gamma-hydroxybutyrate is a weak agonist at recombinant GABA(B) receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.2006.00712.X

10.1111/J.1600-0404.2006.00712.X

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference